Binding and Neutralizing Capacity of Respiratory Syncytial Virus (RSV)-Specific Recombinant IgG Against RSV in Human Milk, Gastric and Intestinal Fluids from Infants

Oral administration of pathogen-specific recombinant antibodies may help to prevent infant gastrointestinal (GI) pathogen infection; however, to neutralize an infectious agent, these antibodies must resist degradation in the GI tract. Palivizumab, a recombinant antibody specific for the respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Demers-Mathieu, Veronique, Lueangsakulthai, Jiraporn, Qu, Yunyao, Scottoline, Brian P., Dallas, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400675/
https://www.ncbi.nlm.nih.gov/pubmed/32605037
http://dx.doi.org/10.3390/nu12071904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400675/
https://www.ncbi.nlm.nih.gov/pubmed/32605037
http://dx.doi.org/10.3390/nu12071904

Ejemplares similares